194 related articles for article (PubMed ID: 23056184)
1. Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage.
Fenimore PW; Muhammad MA; Fischer WM; Foley BT; Bakken RR; Thurmond JR; Yusim K; Yoon H; Parker M; Hart MK; Dye JM; Korber B; Kuiken C
PLoS One; 2012; 7(10):e44769. PubMed ID: 23056184
[TBL] [Abstract][Full Text] [Related]
2. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
[TBL] [Abstract][Full Text] [Related]
3. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
[TBL] [Abstract][Full Text] [Related]
4. Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity.
Yusim K; Fischer W; Yoon H; Thurmond J; Fenimore PW; Lauer G; Korber B; Kuiken C
J Gen Virol; 2010 May; 91(Pt 5):1194-206. PubMed ID: 20053820
[TBL] [Abstract][Full Text] [Related]
5. The structural basis for filovirus neutralization by monoclonal antibodies.
King LB; West BR; Schendel SL; Saphire EO
Curr Opin Immunol; 2018 Aug; 53():196-202. PubMed ID: 29940415
[TBL] [Abstract][Full Text] [Related]
6. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
[TBL] [Abstract][Full Text] [Related]
7. Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species.
Zahn R; Gillisen G; Roos A; Koning M; van der Helm E; Spek D; Weijtens M; Grazia Pau M; Radošević K; Weverling GJ; Custers J; Vellinga J; Schuitemaker H; Goudsmit J; Rodríguez A
PLoS One; 2012; 7(12):e44115. PubMed ID: 23236343
[TBL] [Abstract][Full Text] [Related]
8. Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.
Kozak R; He S; Kroeker A; de La Vega MA; Audet J; Wong G; Urfano C; Antonation K; Embury-Hyatt C; Kobinger GP; Qiu X
J Virol; 2016 Oct; 90(20):9209-23. PubMed ID: 27489269
[TBL] [Abstract][Full Text] [Related]
9. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
An LL; Whitton JL
J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365
[TBL] [Abstract][Full Text] [Related]
10. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors' CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design.
Herst CV; Burkholz S; Sidney J; Sette A; Harris PE; Massey S; Brasel T; Cunha-Neto E; Rosa DS; Chao WCH; Carback R; Hodge T; Wang L; Ciotlos S; Lloyd P; Rubsamen R
Vaccine; 2020 Jun; 38(28):4464-4475. PubMed ID: 32418793
[TBL] [Abstract][Full Text] [Related]
11. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
Zou C; Murakoshi H; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674626
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a putative filovirus vaccine: virus-like particles.
Martins KA; Warren TK; Bavari S
Virol Sin; 2013 Apr; 28(2):65-70. PubMed ID: 23385315
[TBL] [Abstract][Full Text] [Related]
13. Combination of three adjuvants enhances the immunogenicity of a recombinant protein containing the CTL epitopes of non-structural proteins of hepatitis C virus.
Kuprianov VV; Nikolaeva LI; Zykova AA; Dedova AV; Grishechkin AE; Kapustin IV; Kotlyarov RY; Ravin NV
Virus Res; 2020 Jul; 284():197984. PubMed ID: 32325116
[TBL] [Abstract][Full Text] [Related]
14. Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes.
Li M; Zeng J; Li R; Wen Z; Cai Y; Wallin J; Shu Y; Du X; Sun C
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670023
[TBL] [Abstract][Full Text] [Related]
15. A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus.
Tsuda Y; Caposio P; Parkins CJ; Botto S; Messaoudi I; Cicin-Sain L; Feldmann H; Jarvis MA
PLoS Negl Trop Dis; 2011 Aug; 5(8):e1275. PubMed ID: 21858240
[TBL] [Abstract][Full Text] [Related]
16. Vaccine research efforts for filoviruses.
Hart MK
Int J Parasitol; 2003 May; 33(5-6):583-95. PubMed ID: 12782057
[TBL] [Abstract][Full Text] [Related]
17. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs.
Mire CE; Geisbert JB; Versteeg KM; Mamaeva N; Agans KN; Geisbert TW; Connor JH
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S384-8. PubMed ID: 25957964
[TBL] [Abstract][Full Text] [Related]
18. Complete protection of the BALB/c and C57BL/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine.
Rahim MN; Wee EG; He S; Audet J; Tierney K; Moyo N; Hannoun Z; Crook A; Baines A; Korber B; Qiu X; Hanke T
PLoS Pathog; 2019 Feb; 15(2):e1007564. PubMed ID: 30817809
[TBL] [Abstract][Full Text] [Related]
19. Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.
Santra S; Liao HX; Zhang R; Muldoon M; Watson S; Fischer W; Theiler J; Szinger J; Balachandran H; Buzby A; Quinn D; Parks RJ; Tsao CY; Carville A; Mansfield KG; Pavlakis GN; Felber BK; Haynes BF; Korber BT; Letvin NL
Nat Med; 2010 Mar; 16(3):324-8. PubMed ID: 20173754
[TBL] [Abstract][Full Text] [Related]
20. Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies.
Rahim MN; Wang M; Wang T; He S; Griffin BD; Kobasa D; Yang R; Du Z; Qiu X
Viruses; 2019 Mar; 11(3):. PubMed ID: 30875741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
